rs543570657
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001144013.2(RGPD3):c.5026A>G(p.Ile1676Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000968 in 1,611,802 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144013.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152108Hom.: 1 Cov.: 27 show subpopulations
GnomAD2 exomes AF: 0.000236 AC: 59AN: 249648 AF XY: 0.000259 show subpopulations
GnomAD4 exome AF: 0.0000918 AC: 134AN: 1459576Hom.: 3 Cov.: 40 AF XY: 0.000139 AC XY: 101AN XY: 726072 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome AF: 0.000145 AC: 22AN: 152226Hom.: 1 Cov.: 27 AF XY: 0.000148 AC XY: 11AN XY: 74424 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5026A>G (p.I1676V) alteration is located in exon 21 (coding exon 21) of the RGPD3 gene. This alteration results from a A to G substitution at nucleotide position 5026, causing the isoleucine (I) at amino acid position 1676 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at